TrialAdvances in therapy2024

PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 Diabetes.

Ponnusamy Saravanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.